Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HIPO
HIPO logo

HIPO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Hippo Holdings Inc (HIPO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
28.700
1 Day change
-0.66%
52 Week Range
38.980
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Hippo Holdings Inc (HIPO) does not present a strong buy opportunity at this time for a beginner investor with a long-term strategy. While the technical indicators show some positive momentum, the lack of significant trading trends, neutral sentiment from hedge funds and insiders, declining financial performance, and lowered analyst price targets suggest a cautious approach. The absence of recent news or significant catalysts further supports a hold recommendation.

Technical Analysis

The MACD histogram is positive at 0.331 and expanding, indicating bullish momentum. RSI is at 75.169, in the neutral zone, not signaling overbought or oversold conditions. Moving averages are converging, showing no clear directional trend. The stock is trading near resistance levels (R1: 27.643, R2: 28.355), suggesting limited immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data indicates a bullish sentiment with a low put-call ratio and high call volume relative to puts. However, overall trading volume is low, and implied volatility is high at 71.64%, suggesting potential risk.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
7

Positive Catalysts

  • The MACD histogram is positive and expanding, indicating short-term bullish momentum. Options data shows a bullish sentiment with a low put-call ratio.

Neutral/Negative Catalysts

  • Lowered analyst price targets from $34 to $30 over the past month, with a Market Perform rating. Financial performance shows a significant drop in net income (-86.43% YoY) and EPS (-86.52% YoY). No recent news or significant trading trends from hedge funds, insiders, or congress members. High implied volatility (71.64%) indicates potential risk.

Financial Performance

In Q4 2025, revenue increased by 18.16% YoY to $120.4M, but net income dropped by 86.43% YoY to $6M. EPS also declined by 86.52% YoY to 0.24. Gross margin remained unchanged at 0%. Overall, the financial performance shows growth in revenue but significant declines in profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets from $34 to $30 in the past month, maintaining a Market Perform rating. The analyst notes risks associated with strong growth amid softening pricing.

Wall Street analysts forecast HIPO stock price to rise
1 Analyst Rating
Wall Street analysts forecast HIPO stock price to rise
0 Buy
1 Hold
0 Sell
Hold
Current: 28.890
sliders
Low
34
Averages
34
High
34
Current: 28.890
sliders
Low
34
Averages
34
High
34
B. Riley
Timothy D'Agostino
initiated
$38
AI Analysis
2026-04-17
New
Reason
B. Riley
Timothy D'Agostino
Price Target
$38
AI Analysis
2026-04-17
New
initiated
Reason
B. Riley analyst Timothy D'Agostino resumed coverage of Hippo with a Buy rating and $38 price target, implying a potential return of 37%. The firm believes the company's shift in underwriting mix to diversify across personal and commercial lines while continuing to primarily focus on homeowners insurance is attractive. Diversifying across these lines will likely help with Hippo's risk over time, the analyst tells investors in a research note.
Keefe Bruyette
Market Perform
downgrade
$33 -> $30
2026-04-07
Reason
Keefe Bruyette
Price Target
$33 -> $30
2026-04-07
downgrade
Market Perform
Reason
Keefe Bruyette lowered the firm's price target on Hippo to $30 from $33 and keeps a Market Perform rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HIPO
Unlock Now

People Also Watch